Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1995 Mar;36(3):459-61.
doi: 10.1136/gut.36.3.459.

Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis

Affiliations
Case Reports

Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis

L D Jackson et al. Gut. 1995 Mar.

Abstract

A 17 year old Asian patient with autoimmune chronic active hepatitis resistant to treatment with high dose corticosteroids and azathioprine was given cyclosporin at a dose of 5 mg/kg/day. Within two weeks of starting the cyclosporin treatment a favourable clinical and biochemical response was obtained and by one month serum aminotransferase activities were within normal limits. An attempted reduction in the daily dose of cyclosporin resulted in a relapse of the patient's disease. Remission was again attained by returning the dose of cyclosporin to 5 mg/kg/day. No significant side effects of the treatment have been shown. Cyclosporin seems to have a role in the treatment of corticosteroid resistant autoimmune chronic active hepatitis and its further evaluation is warranted.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Med. 1969 Nov;47(5):765-74 - PubMed
    1. N Engl J Med. 1992 Jun 18;326(25):1654-60 - PubMed
    1. Science. 1972 Jun 23;176(4041):1324-5 - PubMed
    1. Lancet. 1973 Apr 7;1(7806):735-7 - PubMed
    1. Gut. 1975 Nov;16(11):876-83 - PubMed

Publication types